A subset of bone marrow samples that displayed a high frequency of CTC-IGC from the prostate cancer patient cohort (Fig. 1) were stained with HOMER1, TNFRSF9, and LRP1 (Fig. 6A). This evidence concerns the gene HOMER1 and prostate carcinoma.